Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kyle Gano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Charles Gorman - $37.82M of NBIX open-market activity in the last 12 months
- Julie Cooke - $5.77M of NBIX open-market activity in the last 12 months
- Stephen A. Sherwin - $4.13M of NBIX open-market activity in the last 12 months
- Ingrid Delaet - $3.75M of NBIX open-market activity in the last 12 months
- Darin Lippoldt - $3.50M of NBIX open-market activity in the last 12 months
- Jude Onyia - $3.47M of NBIX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kyle Gano?
Kyle Gano is a corporate insider, tracked as Chief Executive Officer, Director of NEUROCRINE BIOSCIENCES INC (NBIX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kyle Gano last file a Form 4?
The most recent primary Form 4 on record is dated 17 February 2026, one of 5 filings going back to 2024.
Has Kyle Gano been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($4.87M) across all tracked filings.
Where can I see all of Kyle Gano's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kyle Gano and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
